参考文献/References:
[1]Bender MT,Niederman MS.Improving outcomes in community-acquired pneumonia[J].Current Opinion in Pulmonary Medicine,2016,22(3):235-242. [2]Ouellette DR,Moscoso EE,Corrales JP,et al.Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis:comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin[J].Annals of Intensive Care,2015,5(1):9-16. [3]Angus DC,van der Poll T.Severe sepsis and septic shock[J].N Engl J Med,2013,369(9):840-851. [4]Seeley EJ,Matthay MA,Wolters PJ.Inflection points in sepsis biology: from local defense to systemic organ injury[J].American Journal of Physiology-Lung Cellular and Molecular Physiology,2012,303(5):L355-L363. [5]Glück T,Silver J,Epstein M,et al.Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis[J].European Journal of Medical Research,2001,6(8):351-358. [6]Winkler MS,Rissiek A,Priefler M,et al.Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response:A diagnostic tool for immunosuppression?[J].PLoS One,2017,12(8):e0182427. [7]中华医学会呼吸病学分会.中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志,2016,4(39):1-27. [8]Singer M,Deutschman CS,Seymour CW,et al.The Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)[J].The Journal of the American Medical Association,2016, 315(8):775-787. [9]赖丽仁.新型脓毒症生物标志物Presepsin(sCD14-亚型)的研究进展[J].中华重症医学电子杂志,2017, 3(3):178-181. [10]Yaegashi Y,Shirakawa K,Sato N,et al.Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis[J].Journal of Infection&Chemotherapy,2005,11(5):234-238. [11]Kitchens RL,Thompson PA,Viriyakosol S,et al.Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins[J].Journal of Clinical Investigation, 2001,108(3):485-493. [12]Masson S,Caironi P,Fanizza C,et al.Erratum to:Circulating presepsin(soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock:data from the multicenter,randomized ALBIOS trial[J].Intensive Care Medicine,2014,41(1):12-20. [13]Lekkou A,Karakantza M,Mouzaki A,et al.Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections[J].Clin Diagn Lab Immunol,2004,11(1):161-167. [14]苏磊,周殿元,唐柚青,等.CD14+单核细胞人白细胞DR抗原在脓毒症早期检测中的临床意义[J].中华危重病急救医学,2006,18(11):677-679.
相似文献/References:
[1]赵建美,邵 岩.血必净治疗社区获得性肺炎的研究进展[J].医学信息,2018,31(02):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
ZHAO Jian-mei,SHAO Yan.Research Progress of Xuebijing in Treating Community Acquired Pneumonia[J].Medical Information,2018,31(02):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
[2]包克珍,许云丽.新生儿社区获得性肺炎的临床特征分析[J].医学信息,2018,31(02):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
BAO Ke-zhen,XU Yun-li.Clinical Characteristics of Neonatal Community Acquired Pneumonia[J].Medical Information,2018,31(02):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
[3]赵建美,邵 岩,李京津.电脑中频药透对治疗老年社区获得性肺炎的疗效分析[J].医学信息,2018,31(03):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
ZHAO Jian-mei,SHAO Yan,LI Jing-jin.Analysis of the Efficacy of Computer Medium Frequency Drug Penetration in the Treatment of Elderly Community-acquired Pneumonia[J].Medical Information,2018,31(02):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
[4]曹立杰,杨林瀛,于国云,等.N-末端脑钠肽前体与社区获得性肺炎患者严重程度关系研究[J].医学信息,2018,31(04):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
CAO Li-jie,YANG Lin-ying,YU Guo-yun,et al.Study on the Relationship between N-terminal Brain Natriuretic Peptide Precursors and the Severity of Community-acquired Pneumonia[J].Medical Information,2018,31(02):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
[5]俞 静,赵 红,金 晶,等.社区获得性肺炎胸部CT中反晕征的初步研究[J].医学信息,2022,35(10):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
YU Jing,ZHAO Hong,JIN Jing,et al.Preliminary Study of Reversed Halo Sign in Chest CT of Community-acquired Pneumonia[J].Medical Information,2022,35(02):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
[6]温占兵.血管生成素-1水平变化预测脓毒症急性肺损伤的价值[J].医学信息,2018,31(13):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
WEN Zhan-bing.The Value of Angiopoietin-1 Level Change in Predicting Acute Lung Injury in Sepsis[J].Medical Information,2018,31(02):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
[7]武珊珊.喜炎平注射液治疗社区获得性肺炎临床疗效的Meta分析[J].医学信息,2018,31(14):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
WU Shan-shan.Meta-analysis of Clinical Efficacy of Xiyanping Injection in the Treatment of
Community-acquired Pneumonia[J].Medical Information,2018,31(02):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
[8]徐安林,刘 忠.不同配比的哌拉西林-他唑巴坦治疗
老年性社区获得性肺炎的疗效对比[J].医学信息,2018,31(15):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
XU An-lin,LIU Zhong.Comparison of the Efficacy of Different Ratios of Piperacillin-tazobactam in Elderly Community Acquired Pneumoni[J].Medical Information,2018,31(02):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
[9]许 俊.慢性阻塞性肺疾病急性加重期与慢性阻塞性肺疾病并发社区获得性肺炎患者的临床对比[J].医学信息,2018,31(22):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
XU Jun.Clinical Comparison of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Complicated with Community Acquired Pneumonia[J].Medical Information,2018,31(02):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
[10]远 颖.成人社区获得性肺炎中医药研究[J].医学信息,2018,31(23):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
YUAN Ying.Traditional Chinese Medicine Research on Adult Community Acquired Pneumonia[J].Medical Information,2018,31(02):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]